ConductScience.org, home

Gene · 910

CD1B: CD1b molecule

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CD1B: CD1b molecule. Genes, record 910. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/910

On this page

Gene

Symbol
CD1B
HGNC
Name
CD1b molecule
HGNC
NCBI Gene ID
910
NCBI Gene
HGNC ID
HGNC:1635
HGNC
Ensembl
ENSG00000158485
NCBI Gene
Aliases
CD1, R1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P29016T-cell surface glycoprotein CD1b33328Ensembl, GeneID, HGNC

Source UniProt

Patents34

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440466P29016Espacenet
JP 2025529142 A2025-09-04780P29016Espacenet
US 12371689 B22025-07-29780P29016Espacenet
EP 4487869 A22025-01-0859P29016Espacenet
KR 1020240027895 A2024-03-04251P29016Espacenet
JP 2023036863 A2023-03-14251P29016Espacenet
US 11446398 B22022-09-2012945P29016Espacenet
US 11400116 B22022-08-022456P29016Espacenet
JP 2022524081 A2022-04-27115916P29016Espacenet
US 11078247 B22021-08-031800P29016Espacenet

1 to 10 of 34

See all 34 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,440

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCD1B papersNewest fiscal year
R01AI049313T cell responses to CD1-restricted lipids in tuberculosis542025
R01AI045889Precision Targeting of CD1-Restricted iNKT Cells for Cancer Immunotherapy182025
R01AI022553Molecular Analysis of Host Immune Response in Leprosy152025
R01AR040312CD1-restricted T-cell Responses in Skin152025
P30AR069625Human Skin Disease Resource-based Center62025
R01DK044319Characterization of Mucosal Lymphocytes62025
P30CA016672Cancer Center Support Grant52025
R01AI146072The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis52025
R01GM049758Structure and Function of Metalloenzymes52025
R24AI059830A Xenopus Laevis Research Resource for Immunobiology52025

1 to 10 of 1,440Source NIH's project files

See all 1,440 nih grants

Papers2,023

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Identifying dendritic cell heterogeneity and potential risk genes in atopic dermatitis: integrative scRNA-seq, bulk RNA-seq analyses and experimental validation.Front Med (Lausanne)202642718499PubTator, text miningPubMed
Integrated experimental and computational evaluation of atractylenolide III from Tubipora musica for anticancer lead identification.Sci Rep202642716976PubTator, text miningPubMed
In vitro differentiation and phenotypic profiling of Langerhans cell subsets derived from human peripheral blood monocytes.Immunol Res202642704586PubTator, text miningPubMed
Newly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery.Int J Pharm202641916514PubTator, text miningPubMed
Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering.Cells202641892285PubTator, text miningPubMed
Oligomeric lactic acid nanoplastics induce intrauterine growth restriction in mice by disrupting GATA2-mediated placental vascular development.PLoS Biol202641886399PubTator, text miningPubMed
Mechanistic insights into the therapeutic properties of delta opioid receptor.Sci Adv202641880505PubTator, text miningPubMed
Whole transcriptome sequencing identifies key characteristics and potential therapeutic efficacy biomarkers CD1B, CD247, and CCNB1 in cured tuberculosis patients.Int J Infect Dis202641871736PubTator, text miningPubMed
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment.Int J Nanomedicine202641783547PubTator, text miningPubMed
Correction: Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses.Front Immunol202641766885PubTator, text miningPubMed

1 to 10 of 2,023

See all 2,023 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/910

GET https://conductscience.org/api/genes/v1/910/patents?page=2